{"id":"tqh2722-injection","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Unfortunately, there is limited information available on the exact mechanism of action of TQH2722 injection.","oneSentence":"TQH2722 injection's mechanism is not publicly available.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:54:25.041Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07398859","phase":"PHASE2","title":"Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis","status":"RECRUITING","sponsor":"Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.","startDate":"2026-03-19","conditions":"Seasonal Allergic Rhinitis","enrollment":300},{"nctId":"NCT06439381","phase":"PHASE2","title":"Long-term Safety and Efficacy of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps","status":"RECRUITING","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2024-07-16","conditions":"Chronic Rhinosinusitis","enrollment":120},{"nctId":"NCT06760182","phase":"PHASE2","title":"Clinical Trial of TQH2722 Injection in Patients With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.","startDate":"2025-03-10","conditions":"Seasonal Allergic Rhinitis","enrollment":169},{"nctId":"NCT06089278","phase":"PHASE2","title":"A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps.","status":"COMPLETED","sponsor":"Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.","startDate":"2023-12-28","conditions":"Sinusitis","enrollment":160},{"nctId":"NCT06552520","phase":"PHASE3","title":"To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.","startDate":"2024-09","conditions":"Atopic Dermatitis","enrollment":500},{"nctId":"NCT05970432","phase":"PHASE2","title":"A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis","status":"UNKNOWN","sponsor":"Chia Tai Tianqing Pharmaceutical Group Co., Ltd.","startDate":"2023-06-19","conditions":"Atopic Dermatitis","enrollment":160},{"nctId":"NCT05409326","phase":"PHASE1","title":"A Study of TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult Subjects","status":"UNKNOWN","sponsor":"Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.","startDate":"2022-06","conditions":"Atopic Dermatitis","enrollment":48}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"TQH2722 injection","genericName":"TQH2722 injection","companyName":"Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.","companyId":"shanghai-chia-tai-tianqing-pharmaceutical-technology-development-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"TQH2722 injection is being studied in clinical trials for the treatment of Atopic Dermatitis, Chronic Rhinosinusitis, and Seasonal Allergic Rhinitis. The exact mechanism of TQH2722 injection is currently unknown.","enrichmentLevel":3,"visitCount":2,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}